Our technical scanner runs daily across the S&P 500 and Nasdaq 100, measuring a broad set of indicators — from moving-average crossovers and momentum oscillators to volume patterns and relative strength readings — to flag stocks showing an unusual concentration of bearish signals. The stocks below are today’s top five short candidates: names where the weight of technical evidence points to potential further downside as of 22 July 2026. A short candidate is simply a stock that the scanner identifies as technically weak; it is not a recommendation to sell or short.
Important risk warning: Short selling carries risks that are materially different from — and in many respects greater than — those of buying shares. Losses on a short position are theoretically unlimited, margin requirements can change rapidly, and a short squeeze can force you out of a position at the worst possible moment. Always size positions carefully and use stop-loss discipline.
1. MSCI Inc. (MSCI) – 16 technical sell signals
Price: $561.74 | Daily change: -10.14%
View the full technical analysis of MSCI Inc.
MSCI leads today’s list with the highest bear-signal count, and the price action reinforces the technical picture. Shares dropped sharply after the company released its second-quarter 2026 results, even though adjusted earnings of $4.94 per share came in marginally ahead of consensus and revenues rose roughly 12% year on year to $867 million. Markets appear to have focused on the broader cost trajectory rather than the headline beat, echoing an earlier report noting that rising expenses weighed on the earnings quality.
Adding to the caution, MSCI’s management signalled during the earnings call that sustainability and climate recurring net new sales are expected to be roughly flat to slightly negative over the next two quarters, as the company redirects investment towards artificial intelligence and private-assets capabilities. While that strategic pivot may prove sound over time, it introduces near-term revenue uncertainty in a segment that had previously been a growth driver.
From a technical standpoint, a double-digit single-day decline on elevated volume is rarely a healthy sign. With 16 bearish signals against only 4 bullish ones, momentum, trend and breadth indicators are broadly aligned to the downside. Bears will watch whether the stock can find support at current levels or continues to unwind.
2. Colgate-Palmolive (CL) – 15 technical sell signals
Price: $90.50 | Daily change: -1.56%
View the full technical analysis of Colgate-Palmolive
Colgate-Palmolive scores 15 bearish signals against a solitary bullish one — among the most lopsided ratios on today’s list. The stock’s defensive, consumer-staples profile has attracted positive fundamental commentary in recent months, including a Morgan Stanley price-target increase and commentary that the shares may be modestly undervalued relative to the company’s margin-expansion story. Yet the technical picture tells a different story: price, trend and momentum indicators are broadly aligned to the downside.
Recent fundamental debate has centred on whether Colgate’s impressive 60.4% gross margin and strong free cash flow yield justify the current valuation, or whether the upside from margin expansion is already reflected in the share price. That question of whether good news is fully priced in is relevant for the technical setup: stocks that have already discounted positive catalysts can drift lower even in the absence of bad news.
It is worth noting that Colgate remains a robust, cash-generative business with a long dividend history, which means any short position faces the headwind of both the dividend and the stock’s potential appeal as a defensive holding in a risk-off environment. Prospective shorts should weigh this carefully when sizing any position.
3. Danaher Corporation (DHR) – 15 technical sell signals
Price: $179.01 | Daily change: -10.99%
View the full technical analysis of Danaher Corporation
Danaher is today’s worst performer by daily price change, shedding nearly 11% on 22 July despite reporting second-quarter results that exceeded analyst expectations at the earnings-per-share level. The disconnect between the headline beat and the severe share-price reaction is a recurring pattern for the stock: a similar dynamic was observed in early July, when shares dropped more than 13% after management flagged what analysts described as surprisingly soft bioprocessing sales in one business segment.
That bioprocessing weakness appears to remain the market’s central concern. Danaher’s life-sciences and diagnostics divisions are closely followed as a proxy for broader biopharma capital spending trends, and sluggishness in that area can prompt significant multiple compression. When a high-quality, premium-valued company repeatedly disappoints on a key segment metric, the market tends to reassess the valuation framework more broadly.
Technically, two large-gap-down sessions within roughly three weeks have inflicted considerable damage on the chart. Moving averages are rolling over, and the 15 bearish signals captured by the scanner confirm broad deterioration across multiple indicator categories. Traders considering a short position should nevertheless be aware that Danaher’s long-term compounding track record may attract value-oriented buyers at lower levels, limiting the downside runway.
4. Xylem Inc. (XYL) – 14 technical sell signals
Price: $117.00 | Daily change: -3.0%
View the full technical analysis of Xylem Inc.
Xylem, the water-technology specialist, appears on today’s list with 14 bearish signals and only 1 bullish one. The stock had enjoyed a period of positive momentum in mid-2025, rising sharply on the back of a notable partnership announcement and delivering record results in early 2026. More recently, however, Jefferies suggested the shares could be poised for a catch-up rally relative to peers — yet the technical scanner is telling the opposite story, with a majority of indicators pointing lower.
The tension between a constructive fundamental narrative and deteriorating technical conditions is worth taking seriously. Xylem operates in the water infrastructure and treatment space, an area with strong long-term secular tailwinds around water scarcity and infrastructure investment. Nevertheless, short-term price action and momentum do not always track long-term thematic stories, and the current technical weakness suggests that near-term selling pressure is outweighing those longer-term considerations.
With a short interest of around 3.44% of shares outstanding, the stock is not heavily shorted, which could limit the risk of a short squeeze but also suggests the market has not yet broadly embraced the bear case. Traders should monitor upcoming earnings and sector newsflow closely before initiating or maintaining any short exposure.
5. Ecolab (ECL) – 13 technical sell signals
Price: $264.20 | Daily change: -1.66%
View the full technical analysis of Ecolab
Ecolab rounds out the list with 13 bearish technical signals. The specialty-chemicals and water-treatment company occupies an interesting position fundamentally: Citi recently raised its price target and named Ecolab a top pick in the specialty chemicals space ahead of second-quarter results, while a separate analysis described the stock as a high-quality business trading at a fair — rather than cheap — valuation near current levels. The stock also features in Bill Gates’s publicly disclosed portfolio, lending it a degree of high-profile endorsement.
Despite that supportive fundamental backdrop, Ecolab’s shares declined on a day when the broader S&P 500 rose close to 0.9%, underperforming the market by a meaningful margin. Relative weakness on a strong tape is often one of the more telling signals a technical analyst can observe, and it is consistent with the 13 bearish indicators the scanner has identified across momentum, trend-following and breadth measures.
Potential shorts should note that Ecolab is a dividend aristocrat with consistent free cash flow generation, characteristics that tend to attract long-term institutional holders who may provide a demand cushion on weakness. As always, the gap between a technically weak chart and a fundamentally sound business requires careful risk management if one is considering a short position.
Disclaimer: This blog post is produced for informational and educational purposes only and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Technical analysis identifies patterns in historical price and volume data; it cannot predict future price movements with certainty. Short selling involves significant risks, including the possibility of unlimited losses. Always conduct your own due diligence and consult a qualified financial adviser before making any investment decision. The Wall Street Stock Investors Club and its contributors may hold positions in securities mentioned.